Fineotex Chemical Ltd Q2 FY2026 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/n66gw8yx8dfrcotfwkuybevo.pdf

Key Takeaways


The CrudeChem Acquisition

Tibrewala: “It's not at all a distressed asset at all, and we are already planning a lot of executions of orders going forward.”

CrudeChem’s Financial Profile & Integration


Cross-Selling & Market Expansion

Tibrewala: “The biggest oil serving companies in USA are customers of CrudeChem. That's the way it is.”

The $200 Million Mission

Tibrewala: “I will be the most happiest person if I could answer precisely the question. But as you know, we work in an ecosystem where geopolitical situations and a lot of things move in and out. Even the crude oil price changes a lot.”

Management’s Track Record & Discipline

Tibrewala: “We are a long term company, as you might have studied. If not, maybe if once you study about Fineotex, you will understand the kind of company we are from. It's a long, sustainable growth story here we have, proven history.”

Guidance & Commitments

CommitmentSpecificsTimeline
CrudeChem P&L consolidationConsolidation begins from Dec 15, 2025; Jan 1, 2026 is the key date for visible differencesDec 2025 / Jan 2026
CrudeChem growth rateAt least 25% CAGR for CCT going forwardOngoing, no end date
US capacity expansionInvestments of more than $10 million in plant and machinery in coming yearsComing years
CrudeChem premises shiftFinalizing new premises within a week; move in a couple of monthsWeeks to months
Order book clarityA lot of things will be cleared up regarding orders, approvals and transitionsIn a couple of quarters
Middle East facilitiesTargeting to have facilities in the Middle EastNo date
Funding methodAll CrudeChem investments and working capital from internal accruals and cash; no debtOngoing

Key Metrics

MetricQ2 FY26
Combined annual revenue of acquired groupUSD 68 million, across four U.S.-based specialty chemical companies forming the CCT Technologies Group ecosystem
Stake acquired53.33% controlling stake across the four entities
Acquisition valueapproximately $11.5 million, making the acquisition EPS-accretive
Implied enterprise valuearound $22 million (per an analyst's math)
Price-to-sales ratio0.3x, based on $22 million EV and $68 million sales (per an analyst's math)
Primary capital infusion planned$25 million to $30 million to be introduced into the company as a primary issue for growth
Acquired group EBITDA (current year estimate)almost $4 million to $4.5 million
Acquired group debt positiondebt-free company
Acquisition multiplefive times multiple
P/E or EBITDA to EV ratioabove 5 at the moment
Planned future investment in plant and machinerymore than $10 million going forward
Fineotex cash and bank balancemore than ₹300 crores, around ₹340 crores in September results
Fineotex historical revenue CAGR (last 5 years)45% CAGR growth
Fineotex historical revenue CAGR (last 14-15 years)30% CAGR growth
Expected CCT revenue CAGR going forwardat least 25% CAGR growth expected
Strategic revenue mission for CCT$200 million revenue target, expected in the next 4 years
Additional stake acquisition commitmentadditional 25% in January 2028, taking total stake to 78.33%
North American oilfield chemicals market size$11.5 billion opportunity in 2025